ISCHEMIC HEART DISEASE

This monograph provides a comprehensive analysis of the pathogenesis clinical course and pharmacotherapeutic approaches to ischemic heart disease (IHD). IHD a condition resulting from inadequate blood supply to the heart muscle or complete cessation of blood flow can lead to conditions such as myocardial infarction angina and other cardiovascular disorders. The monograph delves into the molecular and cellular mechanisms involved in the development of IHD primarily focusing on atherosclerosis and the narrowing of blood vessels. It describes key clinical features symptoms diagnostic methods and the latest treatment strategies. Additionally the effectiveness of pharmacotherapy approaches including the role of angiotensin-converting enzyme (ACE) inhibitors beta-blockers statins and thrombolytic agents is explored in detail.